INT162843

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.11
First Reported 2004
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 2.79
Pain Relevance 0.45

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (CP) oxidoreductase activity (CP) extracellular region (CP)
transmembrane transport (CP)
Anatomy Link Frequency
edge 2
CP (Homo sapiens)
Pain Link Frequency Relevance Heat
gABA 29 91.72 High High
Glutamate 17 84.64 Quite High
Neurotransmitter 6 83.60 Quite High
Pain 3 71.56 Quite High
imagery 4 5.00 Very Low Very Low Very Low
cerebral cortex 2 5.00 Very Low Very Low Very Low
agonist 2 5.00 Very Low Very Low Very Low
GABAergic 2 5.00 Very Low Very Low Very Low
cva 2 5.00 Very Low Very Low Very Low
hyperexcitability 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cerebral Palsy 53 100.00 Very High Very High Very High
Spasticity 20 100.00 Very High Very High Very High
Premature Aging 1 100.00 Very High Very High Very High
Aging 2 98.14 Very High Very High Very High
Generalized Anxiety Disorder 17 94.08 High High
Congenital Anomalies 2 79.92 Quite High
Intellectual Impairment 5 77.76 Quite High
Chronic Fatigue Syndrome 1 72.24 Quite High
Pain 1 71.56 Quite High
Injury 1 65.24 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The goals of the workshop were to (1) define the current incidence and prevalence of CP, (2) review the known complications for persons aging with CP, (3) review current understanding of physiological processes that may contribute to loss of function and premature aging in CP, (4) evaluate current treatment interventions in terms of long-term outcomes, (5) identify cutting-edge technologies in neurorehabilitation that may help prevent or treat the effects of accelerated aging for persons diagnosed with CP, and (6) identify strategies to ensure that individuals with CP receive evidence-based care as they transition from pediatric to adult-care services.
Negative_regulation (loss) of Gene_expression (aging) of CP in edge associated with premature aging, aging and cerebral palsy
1) Confidence 0.11 Published 2009 Journal Dev Med Child Neurol Section Abstract Doc Link 19740204 Disease Relevance 1.35 Pain Relevance 0.07
We therefore performed detailed mutational screening of GAD1 in familial spastic CP probands and unaffected family members.


Negative_regulation (screening) of Gene_expression (probands) of CP associated with spasticity and cerebral palsy
2) Confidence 0.03 Published 2004 Journal BMC Neurol Section Body Doc Link PMC544830 Disease Relevance 1.44 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox